| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | UBS reiterates Buy on Keurig Dr Pepper stock ahead of earnings | ||
| Fr | UBS cuts Vail Resorts stock price target on weather challenges | ||
| Fr | UBS cuts Philip Morris stock price target on ZYN volume concerns | ||
| Fr | UBS raises APA stock price target to $45 on Egypt growth outlook | ||
| Fr | Brinker stock maintains Buy rating at UBS on chicken sandwich launch | ||
| Fr | Peter Gyllenhammar increases stake in DCI Advisors to 8.62% | ||
| Fr | Truist raises Bank of New York Mellon stock price target on fees | ||
| Fr | Truist reiterates Eli Lilly stock rating on positive trial data | ||
| Fr | Truist cuts U.S. Bancorp stock price target to $62 on NIM outlook | ||
| Fr | UBS reiterates Buy on Summit Therapeutics stock ahead of trial data | ||
| Fr | Jefferies raises Vale stock price target to $21 on production beat | ||
| Fr | Piper Sandler cuts ICU Medical stock price target on freight costs | ||
| Fr | Truist raises Citizens Financial stock price target on earnings path | ||
| Fr | Piper Sandler cuts Merit Medical stock price target on model update | ||
| Fr | Piper Sandler cuts Abbott Labs stock price target on weak diabetes sales | ||
| Fr | Piper Sandler raises Netflix stock price target on steady results | ||
| Fr | Why is Strategy stock surging today? | ||
| Fr | FNB Q1 2026 slides: profitability rises as revenue misses target | ||
| Fr | Seven & i FY2025 slides: transformation drives record earnings | ||
| Fr | UBS reiterates Buy rating on Pepsico stock after Q1 beat | ||
| Fr | Piper Sandler reiterates Overweight on Ulta Beauty stock at $725 | ||
| Fr | KeyBanc reiterates Digital Realty Trust stock rating on growth outlook | ||
| Fr | Equinix stock price target maintained at $1,075 by KeyBanc | ||
| Fr | KeyBanc reiterates Netflix stock rating on steady outlook | ||
| Fr | TD Cowen reiterates Edwards Lifesciences stock rating on TAVR strength |